🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cutaneous Melanoma, Stage II

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients NCT01638676Phase 1, Phase 21 site📍 Louisville University of Louisville · Tests: Vemurafenib, Metformin COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study NCT07354152n/a1 site📍 Nantes Nantes University Hospital Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma NCT07349303Phase 21 site📍 Gothenburg Vastra Gotaland Region · Tests: Pembrolizumab, Placebo Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study NCT07050940NA5 sites📍 Bari📍 Torino📍 Bari Azienda Ospedaliera di Perugia · Tests: Postbiotic, AntiPD1 Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma NCT06643286NA4 sites📍 Dordrecht📍 Rotterdam📍 Rotterdam Erasmus Medical Center · Tests: Digizorg Melanoma app Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma NCT06240143Phase 1, Phase 26 sites📍 Amsterdam📍 Amsterdam📍 Groningen The Netherlands Cancer Institute · Tests: Ipilimumab, Nivolumab, Nivolumab Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial NCT06965231Phase 24 sites📍 Shanghai📍 Shanghai📍 Shanghai Fudan University · Tests: Toripalimab combined with Endostar A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information NCT07621614Phase 213 sites📍 Oakland📍 Wilmington📍 Jacksonville Children's Oncology Group · Tests: Biospecimen Collection, Chest Radiography, Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers NCT05296564Phase 1, Phase 21 site📍 Jerusalem Hadassah Medical Organization · Tests: CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide, HBI 0201-ESO TCRT, Aldesleukin Neoadjuvant Tebentafusp for Uveal Melanoma NCT06414590Phase 22 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma NCT04126876Phase 21 site📍 Amsterdam A.J.M. van den Eertwegh · Tests: Tilsotolimod, Saline (0.9% sodium chloride) Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary NCT02828202n/a27 sites📍 Amiens📍 Annecy📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Biological, Tissular, Quality of life Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC NCT07718243Phase 1, Phase 22 sites📍 Manchester📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Bexmarilimab 1mg/kg and nivolumab 1mg/kg, Bexmarilimab 3mg/kg and nivolumab 1mg/kg, Recommended Phase II Dose Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma NCT04331093Phase 21 site📍 Changchun Di Wu · Tests: SHR-1210+Apatinib Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site📍 Columbus Carlo Contreras · Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma NCT03860883NA192 sites📍 Mobile📍 Gilbert📍 Phoenix Melanoma and Skin Cancer Trials Limited · Tests: Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Non-Interventional Study Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases NCT05026983Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Binimetinib, Encorafenib, Questionnaire Administration NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma NCT06651151Phase 21 site📍 Oslo Oslo University Hospital · Tests: LTX-315 + pembrolizumab A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites📍 Phoenix📍 San Francisco📍 Hartford BioNTech SE · Tests: BNT326, Pumitamig, Itraconazole, Paroxetine Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma NCT05527795n/a1 site📍 Pierre-Bénite Hospices Civils de Lyon · Tests: Frequency and duration of response to adjuvant immunotherapy according to clinical features, Frequency of each type of … NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma NCT07680699n/a1 site📍 São Paulo AC Camargo Cancer Center · Tests: Anti-PD1 Therapy Timing Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) NCT06999980Phase 21 site📍 Wollstonecraft Melanoma Institute Australia · Tests: Ipilimumab 3mg/kg and nivolumab 1mg/kg, Ipilimumab 1mg/kg Nivolumab 480mg and relatlimab 160mg, Nivolumab 480mg and rel… A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma NCT03116412NA20 sites📍 Borås📍 Eskilstuna📍 Falun Uppsala University · Tests: CT or PET scans Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) NCT03340129Phase 29 sites📍 Sydney📍 Waratah📍 Wollstonecraft Melanoma Institute Australia · Tests: Ipilimumab, Nivolumab, Stereotactic Radiotherapy, Salvage therapy Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study NCT05136196Phase 2232 sites📍 Phoenix📍 Little Rock📍 Beverly Hills National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate, Computed Tomography, Magnetic Resonance Imaging Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma NCT05428007Phase 24 sites📍 Los Angeles📍 Boston📍 Boston NYU Langone Health · Tests: Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy